Skip to main content
Midas Edge

VOLITIONRX LTD

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

VNRX$0.18-7.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Deficit

Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)

** For the Three and Six Months ended June 30, 2026 and June 30, 2025**

Accumulated
Additional · Other · Non -
Common Stock · Paid-in · Comprehensive · Accumulated · Controlling
SharesAmountCapitalIncomeDeficitInterestTotal
#$$$$$$
Balance, December 31, 20256,288,9886,289218,943,759(295,071)(252,901,370)(1,346,418)(35,592,811)
Common stock issued for cash, net of issuance costs1,000,6811,0015,172,803---5,173,804
Common stock issued for settlement of RSUs25,91526(26)----
Issuance of warrants in connection with convertible note offering--615,852---615,852
Fair value of convertible note settlement--2,803,200---2,803,200
Common stock issued for settlement of convertible note repayments615,028615(615)----
Stock-based compensation--224,982---224,982
Tax withholdings paid related to stock-based compensation--(15,706)---(15,706)
Foreign currency translation---134,307--134,307
Net loss for the period----(6,664,774)(38,783)(6,703,557)
Balance, March 31, 20267,930,6127,931227,744,249(160,764)(259,566,144)(1,385,201)(33,359,929)
Common stock issued for cash, net of issuance costs3,425,8853,4255,455,017---5,458,442
Deemed dividend - down round provision in warrants--460,100-(460,100)--
Common stock issued for settlement of RSUs5271(1)----
Fair value of convertible note settlement--1,367,200---1,367,200
Common stock issued for settlement of Convertible note repayments687,315687(687)----
Stock-based compensation--238,002---238,002
Tax withholdings paid related to stock-based compensation--(125)---(125)
Foreign currency translation---72,313--72,313
Net loss for the period----(7,326,047)10,784(7,315,263)
Balance, June 30, 202612,044,33912,044235,263,755(88,451)(267,352,291)(1,374,417)(33,539,360)

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

Accumulated
Additional · Other · Non -
Common Stock · Paid-in · Comprehensive · Accumulated · Controlling
SharesAmountCapitalIncome (Loss)DeficitInterestTotal
#$$$$$$
Balance, December 31, 20244,804,8744,805204,246,287385,631(229,544,343)(1,200,116)(26,107,736)
Common stock issued for cash, net of issuance costs227,6222272,384,427---2,384,654
Common stock issued for settlement of RSUs4,8785(5)----
Stock-based compensation--347,801---347,801
Stock-based compensation in relation to modification of options--103,573---103,573
Tax withholdings paid related to stock-based compensation--(24,411)---(24,411)
Foreign currency translation---(253,929)--(253,929)
Net loss for the period----(5,423,759)(52,868)(5,476,627)
Balance, March 31, 20255,037,3745,037207,057,672131,702(234,968,102)(1,252,984)(29,026,675)
Common stock issued for cash, net of issuance costs16,0781660,588---60,604
Common stock issued for settlement of RSUs47,73548(48)----
Common stock issued for cash, in respect of warrant shares97,914981,860---1,958
Stock-based compensation--812,045---812,045
Issuance of warrants in connection with convertible note offering--1,998,869---1,998,869
Tax withholdings paid related to stock-based compensation--(55,057)---(55,057)
Foreign currency translation---(575,996)--(575,996)
Net loss for the period----(6,284,078)(29,992)(6,314,070)
Balance, June 30, 20255,199,1015,199209,875,929(444,294)(241,252,180)(1,282,976)(33,098,322)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.